This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 28/5/812    most recent ATVBAHA.107.159327v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Doran, A. C. Articles by McNamara, C. A. PubMed PubMed Citation Articles by Doran, A. C. Articles by McNamara, C. A.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:812.)
© 2008 American Heart Association, Inc.

Brief Review

Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis

Amanda C. Doran; Nahum Meller; Coleen A. McNamara

From the Cardiovascular Division/Department of Medicine, the Cardiovascular Research Center, and Department of Molecular Physiology and Biological Physics, University of Virginia Health Sciences Center, Charlottesville.

Correspondence to Coleen A. McNamara, University of Virginia Health Sciences Center, Cardiovascular Division, PO Box 801394, Charlottesville, VA 22908. E-mail cam8c{at}virginia.edu

The initiation of atherosclerosis results from complex interactions of circulating factors and various cell types in the vessel wall, including endothelial cells, lymphocytes, monocytes, and smooth muscle cells (SMCs). Recent reviews highlight the role of activated endothelium and inflammatory cell recruitment in the initiation of and progression of early atherosclerosis. Yet, human autopsy studies, in vitro mechanistic studies, and in vivo correlative data suggest an important role for SMCs in the initiation of atherosclerosis. SMCs are the major producers of extracellular matrix within the vessel wall and in response to atherogenic stimuli can modify the type of matrix proteins produced. In turn, the type of matrix present can affect the lipid content of the developing plaque and the proliferative index of the cells that are adherent to it. SMCs are also capable of functions typically attributed to other cell types. Like macrophages, SMCs can express a variety of receptors for lipid uptake and can form foam-like cells, thereby participating in the early accumulation of plaque lipid. Like endothelial cells, SMCs can also express a variety of adhesion molecules such as vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 to which monocytes and lymphocytes can adhere and migrate into the vessel wall. In addition, through these adhesion molecules, SMCs can also stabilize these cells against apoptosis, thus contributing to the early cellularity of the lesion. Like many cells within the developing plaque, SMCs also produce many cytokines such as PDGF, transforming growth factor-β, IFN, and MCP-1, all of which contribute to the initiation and propagation of the inflammatory response to lipid. Recent advances in SMC-specific gene modulation have enhanced our ability to determine the role of SMCs in early atherogenesis.

Smooth muscle cells (SMCs) play a key role in fibrous cap formation and plaque stability in advanced atherosclerosis; however, less is known about the role of SMCs in the initiation and progression of atherosclerosis. This review summarizes the present data implicating SMCs in the development of early atherogenesis.

Key Words: atherosclerosis • smooth muscle cells • intimal thickening